||Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 527 active entries
Lochhamer Str. 11
Martinsried, 82152, Bavaria
Phone: +49-89-89 56 32-0
Fax: +49-89-89 56 32-20
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
A biopharmaceutical product company, MediGene AG is focussed
on the discovery, development and commercialisation of high
value molecular therapeutics. With strong backing from
Europe's leading finance houses and venture capitalists,
MediGene's experienced management and skilled research teams
have brought together a unique combination of recombinant
tumour vaccines and novel targets and therapeutics for
cardiac diseases. The company's proprietary technologies are
aimed at the treatment of prevalent cancers such as cervical
and ovarian cancer and malignant melanoma, as well as the
treatment of congestive heart failure. Starting in 1995, MediGene has more than 50 employees and has raised over DM 70 million.
Last update of this entry: before October 1999.